Skip to main content

Bleichroeder LP's Form 4 filing

Scientific Industries IncSCND · filed Dec 15, 2023

Accession no.
0001781002-23-000050
Filed
Dec 15, 2023
Trade date
Dec 13, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction and 5 derivative transactions. Open-market purchases total $1.20M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Bleichroeder LPCIK 000178100210% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 13, 2023Common StockPPurchaseAcquired+600,000$2.00F1+$1,200,0001,203,351Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 13, 2023Common StockJOtherDisposed−278,947–F3–0Indirect
Dec 13, 2023Common StockJOtherAcquired+278,947–F3–278,947Indirect
Dec 13, 2023Common StockJOtherDisposed−22,728–F3–0Indirect
Dec 13, 2023Common StockJOtherAcquired+22,728–F3–22,728Indirect
Dec 13, 2023Common StockPPurchaseAcquired+960,000–F1–960,000Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

On December 13, 2023, 21 April Fund, Ltd., 21 April Fund, LP and Scientific Industries Inc. (the "Issuer") entered into an agreement (the "Securities Purchase Agreement") under which 21 April Fund, Ltd. and 21 April Fund, LP purchased from the Issuer, for an aggregate purchase price of $1,200,000, 600,000 shares of Common Stock and warrants to acquire 960,000 shares of Common Stock at an exercise price of $2.50 per share.

Referenced by the price of 1 transaction in Table I and 1 transaction in Table II.

F3

On December 13, 2023, the Issuer amended the terms of (x) the 278,947 warrants with an exercise price of $9.50 per share and (y) the 22,728 warrants with an exercise price of $5.50 per share to, among other things, (i) reduce the exercise price to $2.50 and (ii) extend their exercise period to the fifth anniversary of the amendment of the warrants.

Referenced by the price of 4 transactions in Table II.

Read the full filing on SEC EDGAR (opens in a new tab)